GLUE NASDAQ
Monte Rosa Therapeutics, Inc.
1W: +1.1%
1M: -10.0%
3M: -0.5%
YTD: +23.3%
1Y: +353.9%
3Y: +237.8%
$18.81
-0.07 (-0.37%)
Weekly Expected Move ±7.0%
$16
$17
$18
$19
$21
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$43M
Revenue
-73.1% YoY
$-130M
Net Income
-2213.0% YoY
$-20M
Free Cash Flow
-164.5% YoY
51.8%
Gross Margin
-1188.5%
Op. Margin
-1057.1%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-57.0%
ROA-29.3%
ROIC111.7%
Valuation
P/E-9.5
P/B2.4
EV/EBITDA-5.4
Leverage
Debt/Equity0.17
Current Ratio6.12
Interest Cov.0.0x
Quality Scores
Piotroski F4/9
Altman Z1.42
Beneish M484.65